Interview with Robert Dahan, President, AstraZeneca France
You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of…
Address: 1 Place Louis Renault, Rueil-Malmaison cedex 92844,France
Tel: 33 (0)1 41 29 40 00
Web: http://www.astrazeneca.fr/accueil/
AstraZeneca provides medical professionals and patients know how and drugs already widely recognized. The French subsidiary of AstraZeneca was the first European subsidiary of the group and the third in the world after the United States and Japan.
With a turnover of 1.23 billion euros in 2008, AstraZeneca is the 6th largest pharmaceutical company in France while employing 1,900 people.
In France, AstraZeneca is involved in all stages of the life of the drug research, development, production, marketing. Besides the headquarters in Rueil-Malmaison and medical networks present throughout the territory, the company has a center of Cancer Research in Reims and two industrial sites in Dunkirk and Reims.
AstraZeneca has a broad range of effective drugs and innovative, designed to combat disease in areas where medical needs are greatest.
ANESTHESIA
HEART
GASTROINTESTINAL ENTEROLOGY
INFECTIOLOGY
ONCOLOGY
RESPIRATORY
CENTRAL NERVOUS SYSTEM
You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of…
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…
A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how…
A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s…
Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in…
With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe…
French firm LFB is targeting the lucrative US market with its hemophilia products and recently received two FDA…
French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679…
David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi’s vaccines division, was appointed…
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would…
In a recent interview with Financial Times, Sanofi CEO Paul Hudson set out to clarify some recent comments that the…
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are…
Speaking exclusively to PharmaBoardroom at the International Women’s Day 2020 event at the Franco-British Chamber…